You are here

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma

 

Online download statistics by month:

Online download statistics by month: October 2023 to August 2025

AbstractFullPdf
Oct 202310601063157
Nov 2023607609101
Dec 2023751754123
Jan 202415715959
Feb 202413013058
Mar 202426927172
Apr 202426426673
May 202418018159
Jun 202414614546
Jul 202438138260
Aug 202433333237
Sep 2024337340237
Oct 202436636956
Nov 202437938047
Dec 2024688691144
Jan 2025438439123
Feb 2025438443106
Mar 2025414416107
Apr 2025325338117
May 2025258269100
Jun 202518619092
Jul 2025110
Aug 2025110
Total810981691974